FILE PHOTO: Small bottles labeled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustration taken taken April 10, 2020. REUTERS/Dado Ruvic
(Reuters) - A sixth experimental COVID-19 vaccine from China is now being tested in humans after Clover Biopharmaceuticals said on Friday an early-stage study of its candidate was underway with vaccine boosters from UK's GSK and U.S. based Dynavax .
The trial, which is enrolling about 150 adult and elderly patients, will evaluate the two different boosters, or adjuvants, in combination with Clover's candidate shot, SCB-2019, the Chinese company said. (https://bwnews.pr/2YMttSB)
